Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

1.3K
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
1.3K
Esophageal Achalasia01:27

Esophageal Achalasia

45
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide...
45
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

1.5K
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.5K
Esophagus01:24

Esophagus

4.6K
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
4.6K
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

46
Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
46
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

1.8K
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Csf1r-mediated depletion of myeloid cells prevents dopaminergic neuron loss during chronic colitis.

Journal of neuroinflammation·2026
Same author

In vitro modeling of inflammatory bowel diseases using a newly developed immunocompetent colon epithelial monolayer co-culture model.

npj biomedical innovations·2026
Same author

Coordinated Interferon-γ/Tumor Necrosis Factor axis Drives Selective Loss of Activated Enteric Glia in Inflammatory Bowel Diseases.

Cellular and molecular gastroenterology and hepatology·2026
Same author

The endogenous peptide GPR15L shapes the intestinal microbiota to counteract colitis.

Gut·2026
Same author

Hydrogen sulfide as a therapeutic candidate in diabetic retinopathy: a new perspective from gas medicine.

Medical gas research·2026
Same author

International development of Investigator Global Assessment scores for pemphigus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Related Experiment Video

Updated: May 2, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

1.6K

Esophageal epithelial resistance.

Claudia Günther1, Helmut Neumann, Michael Vieth

  • 1Department of Medicine I, University of Erlangen-Nuremberg, Erlangen, Germany.

Digestive Diseases (Basel, Switzerland)
|March 8, 2014
PubMed
Summary
This summary is machine-generated.

The esophagus acts as a crucial barrier against pathogens and toxins. This review details its defense mechanisms, including epithelial cells, mucins, and defensins, and discusses factors affecting mucosal integrity.

More Related Videos

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

6.5K
Production, Characterization and Potential Uses of a 3D Tissue-engineered Human Esophageal Mucosal Model
12:16

Production, Characterization and Potential Uses of a 3D Tissue-engineered Human Esophageal Mucosal Model

Published on: May 18, 2015

9.7K

Related Experiment Videos

Last Updated: May 2, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

1.6K
Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

6.5K
Production, Characterization and Potential Uses of a 3D Tissue-engineered Human Esophageal Mucosal Model
12:16

Production, Characterization and Potential Uses of a 3D Tissue-engineered Human Esophageal Mucosal Model

Published on: May 18, 2015

9.7K

Area of Science:

  • Gastroenterology
  • Immunology
  • Microbiology

Background:

  • The esophageal tissue serves critical digestive functions and acts as a primary defense barrier against intraluminal pathogens and toxins.
  • This barrier function relies on mechanical, chemical, and immunological mechanisms that are often compromised during inflammatory diseases, leading to mucosal damage.

Purpose of the Study:

  • To review the structural and functional host defense barriers within the esophageal mucosa.
  • To discuss the role of esophageal biofilms and regulators of intestinal permeability in mucosal integrity.

Main Methods:

  • Literature review focusing on esophageal defense mechanisms.
  • Analysis of structural components like the epithelial layer, mucins, and defensins.
  • Examination of factors influencing esophageal permeability, such as zonulin and desmosomal components.

Main Results:

  • The esophageal mucosa possesses multiple layers of defense, including the epithelial barrier, mucins, and defensins.
  • Esophageal biofilms can impact mucosal health.
  • Regulators of intestinal permeability, like zonulin and desmosomes, are crucial for maintaining esophageal barrier function.

Conclusions:

  • Understanding esophageal defense mechanisms is vital for addressing inflammatory diseases.
  • Maintaining the integrity of the esophageal barrier is essential for preventing pathogen invasion and subsequent tissue damage.